Vyome Holdings' ReShape Lifesciences Has Received A Notice Of Allowance For A U.S. Patent Titled "VAGUS NERVE NEUROMODULATION FOR THE TREATMENT OF THE HYPOGLYCEMIC STATE".

Vyome Holdings' subsidiary, ReShape Lifesciences, has received a Notice of Allowance for a U.S. patent concerning 'Vagus Nerve Neuromodulation for the Treatment of the Hypoglycemic State.' This development could enhance the company's position in the medical technology sector. The stock ticker for Vyome Holdings is HIND.